Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Price Target at $33.00

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five ratings firms that are presently covering the stock, MarketBeat reports. Five research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in […]

Related Keywords

,Schonfeld Strategic Advisors ,Insider Transactions At Eyepoint Pharmaceuticals ,Lazard Asset Management ,Nasdaq ,Eyepoint Pharmaceuticals Inc ,Eyepoint Pharmaceuticals Company Profile ,Eyepoint Pharmaceuticals Trading Down ,Cubist Systematic Strategies ,Analyst Recommendations For Eyepoint Pharmaceuticals ,Barclays Plc ,News Ratings For Eyepoint Pharmaceuticals Daily ,Cantor Fitzgerald ,Eyepoint Pharmaceuticals ,Tower Research Capital ,Get Free Report ,Point Pharmaceuticals Trading Down ,Point Pharmaceuticals ,Strategic Advisors ,Research Capital ,Asset Management ,Systematic Strategies ,Get Free ,Eyepoint Pharmaceuticals Daily ,Nasdaq Eypt ,Eypt ,Medical ,Ratings ,Consensus ,